Independent and not affiliated with the FDA, MHRA, ISPE, PDA, or any agency. Get the appgoutham@madhadi.com
madhadi.comData Integrity & GxP Quality
Browse all topics → Articles Templates & Procedures Learning paths GlossaryScenariosToolsRegulatory ReferencesLearning PathsTopics About Start here
Checklist Plug-and-play starting point Cell & Gene Therapy

Checklist: Single-Patient (Autologous) Batch Release Readiness

A plug-and-play pre-release checklist for an autologous cell or gene therapy batch: chain of identity reconciliation, infusion-gating test results, the OOS-release pathway, and for-the-record test tracking, with references and a signoff block.

Document type: Checklist

Read and copy the template below into your own quality system. It is a generic starting point for your own internal use, provided as is, with no warranty; see the Terms and License. Adopting it does not by itself create compliance.

This is a ready-to-use pre-release checklist for a single-patient (autologous) cell or gene therapy batch. Replace every <<FILL: ...>> placeholder with your own specifics. Complete every item before the Qualified Person / responsible quality unit certifies release; do not release with any item unresolved.

Batch identification

FieldEntry
Product<<FILL>>
COI identifier / batch number<<FILL>>
Patient identifier (per your pseudonymization policy)<<FILL>>
Manufacturing site<<FILL>>

Chain of identity and custody

  • COI identifier is consistent across every record from collection to this disposition, with no gaps or transcription errors.
  • Every handoff shows two independent identifiers verified by a named person.
  • Chain of custody record shows no gap in custodianship and the full temperature trace is within band for the entire journey, or any excursion has a documented, QA-approved disposition.

Infusion-gating release panel

  • Identity (cell phenotype) result: <<FILL>>, within spec: Yes / No
  • Transduction efficiency / vector copy number result: <<FILL>>, within spec: Yes / No
  • Viable cell dose result: <<FILL>>, meets target dose: Yes / No
  • Viability result: <<FILL>>, within spec: Yes / No
  • Endotoxin result: <<FILL>>, within spec: Yes / No
  • Rapid sterility result: <<FILL>>, no growth at readout: Yes / No
  • RCR/RCL testing (where required at this stage) complete: Yes / No / Not applicable

If any gating result is out of specification

  • Pre-approved OOS-release SOP reference: <<FILL: SOP-ID>>
  • Documented risk assessment attached: Yes / No
  • Treating physician notified and notification recorded: Yes / No
  • Patient informed per the SOP: Yes / No
  • Joint QP/quality unit and physician authorization recorded: Yes / No

If any box in this section is No, do not release; quarantine and investigate.

For-the-record tests (pending, do not gate infusion)

TestCommitted report dateStatus
Full sterility (compendial)<<FILL>>Pending / Reported
RCR/RCL (post-infusion testing, if applicable)<<FILL>>Pending / Reported
Potency<<FILL>>Pending / Reported
  • A defined process exists to act on any later failure of a for-the-record test (physician notification, investigation, health-authority reporting as applicable).

Final disposition

QuestionAnswer
All infusion-gating tests within spec, or OOS-release pathway completed?Yes / No
COI/COC reconciliation ties out?Yes / No
DispositionRelease / Hold / Reject

Sign-off

RoleNameSignatureDate
QC release reviewer<<FILL>>
Qualified Person (EU) / responsible quality unit (US)<<FILL>>
Treating physician (only if OOS-release pathway used)<<FILL>>

Filled specimen (excerpt)

ItemResultWithin spec?
Identity (cell phenotype)ConformsYes
Viable cell doseMeets targetYes
ViabilityAbove limitYes
EndotoxinBelow limitYes
Rapid sterilityNo growthYes

COI/COC: identifier COI-7F3A21 consistent across all 8 handoff records; no gaps; cold-chain trace within band throughout transport.

Disposition: all gating tests within spec, COI/COC ties out, released by QP with for-the-record tests (full sterility, RCR/RCL, potency) tracked to their committed report dates.

Common inspection findings this checklist prevents

  • A batch released with an infusion-gating test still pending, not yet reported as within spec.
  • An OOS result released without the pre-approved SOP, documented risk assessment, or recorded physician notification.
  • For-the-record tests that fail after infusion with no defined follow-up action.
  • A COI or COC gap discovered after release rather than caught at the disposition checkpoint.

How to adapt this checklist

  1. Set your product’s actual gating panel and specs from your approved control strategy.
  2. Point the OOS-release section to your real, pre-approved SOP; do not leave this section generic at the point of use.
  3. Confirm your for-the-record test list and committed report dates match your validated release strategy.
Use madhadi.com as an app Full screen, works offline, one tap from your home screen.